Literature DB >> 12220646

Involvement of Elk-1 in L6E9 skeletal muscle differentiation.

Ashwani Khurana1, Chinmoy S Dey.   

Abstract

In L6E9 skeletal muscle cells ternary complex factor (TCF) Elk-1 expression increased with the onset of skeletal muscle differentiation, whereas its activation decreased as a function of differentiation. Its expression was predominantly restricted to cytoplasm and activated ones were predominantly restricted to the nucleus of the differentiated cells. Inhibition of ERK-1/-2 activities by PD098059 resulted into significant reduction in Elk-1 expression and phosphorylation during differentiation. In contrast, inhibition of p38 mitogen-activated protein kinase (MAPK) enhanced Elk-1 expression and activation, thereby mediating inhibition of skeletal muscle differentiation. Overexpression of inactive mutant Elk-1 enhanced differentiation. Data suggest that ERK-1/-2 and p38 MAPK activities modulate Elk-1 expression and activation to regulate skeletal muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220646     DOI: 10.1016/s0014-5793(02)03192-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro.

Authors:  N K Verma; C S Dey
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

2.  Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma.

Authors:  An-Guo Chen; Zai-Cheng Yu; Xin-Feng Yu; Wen-Feng Cao; Fang Ding; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.

Authors:  Jiliang Zhou; Guoqing Hu; B Paul Herring
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  Downregulated protein expression of transcriptional activator ELK-1 in atrial myocardium of chronic AF patients.

Authors:  Xiangjun Zeng; Xuejun Xiao; Yueheng Wu; Huanlei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma.

Authors:  Chia-Herng Yue; Chih-Yang Huang; Jen-Hsiang Tsai; Chih-Wei Hsu; Yi-Hsien Hsieh; Ho Lin; Jer-Yuh Liu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  MZF-1/Elk-1/PKCα is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.

Authors:  Je-Chiuan Ye; Li-Sung Hsu; Jen-Hsiang Tsai; Hsin-Ling Yang; Meen-Woon Hsiao; Jin-Ming Hwang; Chia-Jen Lee; Jer-Yuh Liu
Journal:  J Cancer       Date:  2017-09-02       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.